TY - JOUR
T1 - Multiple myeloma laboratory diagnostics made simple
T2 - practical insights and key recommendations
AU - Portuguese Multiple Myeloma Grp
AU - Pires, Ana Marta
AU - Barreto, João Pedro
AU - Caetano, Joana
AU - Soares, Maria José
AU - Geraldes, Catarina
AU - Fernandes, Bruno
AU - Coucelo, Margarida
AU - Chacim, Sérgio
AU - Coelho, Henrique
AU - Correia, Cecília
AU - Cruz, Ana Paula
AU - Cunha, Manuel
AU - Cunha, Maria Rosário
AU - Cunha, Nuno
AU - Ferraz, Patrícia
AU - Freitas, José Guilherme
AU - Henrique, Rui
AU - Lisboa, Susana
AU - Lúcio, Paulo
AU - Paiva, Artur
AU - Pedrosa, Cláudia
AU - Ramos, Inês
AU - Sarmento-Ribeiro, Ana Bela
AU - Seabra, Patricia
AU - Sevilha, Joana
AU - Sousa, Maria José Rego de
AU - Sousa, Sara
AU - Sousa, Teresa
AU - Tavares, Márcio
AU - Trigo, Fernanda
AU - Roque, Adriana
AU - Bergantim, Rui
AU - João, Cristina
N1 - Publisher Copyright:
© 2025 by the authors.
PY - 2025/10/9
Y1 - 2025/10/9
N2 - Multiple myeloma is a clonal plasma cell malignancy with a highly variable range of clinical manifestations. Over recent decades, substantial progress has been made in laboratory diagnostics, which has deepened our understanding of disease biology, improved risk stratification, and informed treatment strategies. In an era of transformation and innovation, conventional laboratory methods remain essential, as cutting-edge technologies might not be immediately accessible to all laboratories. Nonetheless, even widely used laboratory methodologies present many challenges, such as variability in assay performance, interpretative criteria, and standardization. This review by the Portuguese Multiple Myeloma Group of the Portuguese Society of Hematology provides a comprehensive overview and practical appraisal of current conventional laboratory methods employed for multiple myeloma diagnosis.
AB - Multiple myeloma is a clonal plasma cell malignancy with a highly variable range of clinical manifestations. Over recent decades, substantial progress has been made in laboratory diagnostics, which has deepened our understanding of disease biology, improved risk stratification, and informed treatment strategies. In an era of transformation and innovation, conventional laboratory methods remain essential, as cutting-edge technologies might not be immediately accessible to all laboratories. Nonetheless, even widely used laboratory methodologies present many challenges, such as variability in assay performance, interpretative criteria, and standardization. This review by the Portuguese Multiple Myeloma Group of the Portuguese Society of Hematology provides a comprehensive overview and practical appraisal of current conventional laboratory methods employed for multiple myeloma diagnosis.
KW - Diagnosis
KW - Laboratory methodologies
KW - Multiple myeloma
KW - Response assessment
KW - Risk stratification
UR - https://www.scopus.com/pages/publications/105020050894
U2 - 10.3390/jcm14197115
DO - 10.3390/jcm14197115
M3 - Review article
C2 - 41096195
SN - 2077-0383
VL - 14
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 19
M1 - 7115
ER -